Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Elisabeth C. M. Van Pampus"'
Publikováno v:
Transfusion Medicine Reviews, 24(1), 44-52. W.B. Saunders Ltd
The management of dilutional coagulopathy due to fluid infusion and massive blood loss is a topic that deserves a biochemical approach. In this review article, we provide an overview of current guidelines and recommendations on diagnosis and on manag
Autor:
Saskia E M Schols, Marcus D. Lancé, Elisabeth C. M. Van Pampus, Marion A.H. Feijge, Johan W. M. Heemskerk, Hugo ten Cate, Karly Hamulyák
Publikováno v:
Transfusion, 48, 2384-94
Transfusion, 48, 11, pp. 2384-94
Transfusion, 48, 11, pp. 2384-94
Item does not contain fulltext BACKGROUND: Bleeding upon major surgery or severe trauma is treated by transfusion with crystalloids, colloids, or plasma. This treatment, however, can lead to dilutional coagulopathy and impaired hemostasis. We investi
Autor:
Sandra Cauwenberghs, Jan-Willem N. Akkerman, Joyce Curvers, Elisabeth C. M. Van Pampus, Johan W. M. Heemskerk
Publikováno v:
Transfusion Medicine Reviews. 21:287-294
Metabolic studies have revealed a gradual impairment in platelet integrity during storage, a process termed the platelet storage lesion. Recent evidence shows that stored platelets also lose signaling responses to physiological agonists with impaired
Autor:
Johan W. M. Heemskerk, Marion A.H. Feijge, Eva Rombout-Sestrienkova, Peter Giesen, Elisabeth C. M. Van Pampus, Joyce Curvers
Publikováno v:
Transfusion. 44:49-58
BACKGROUND: Circulating PLTs have a low activation state and high responsiveness, which ensures adequate hemostatic activity at sites of vessel wall damage. PLTs collected for transfusion purposes preferably have retained these properties to restore
Autor:
Elisabeth C. M. Van Pampus, Rene van Oerle, Guido Tans, L. G. D. Thomassen, Jan Rosing, Karly Hamulyák, M. Christella, M.R. Nijziel
Publikováno v:
British Journal of Haematology. 120:117-122
Summary. In 56 women with a lymph-node-positive breast carcinoma and 28 matched healthy control subjects, the sensitivity to activated protein C (APC-sr) was determined with an APC resistance test that quantifies the effect of APC on thrombin generat
Autor:
Elisabeth C. M. Van Pampus, Johan R. Meinardi, Karly Hamulyák, Pieter J. De Kam, Saskia Middeldorp, Martin H. Prins, Harry R. Büller, Maria M. W. Koopman, Jan van der Meer
Publikováno v:
British Journal of Haematology. 116:625-631
Summary. The duration of anticoagulant treatment after a first episode of venous thromboembolism primarily depends on the risk of recurrence. Variability of recurrence rates in factor (F) V Leiden carriers may be due to concomitant thrombophilic diso
Autor:
Pieter H. Reitsma, Rendrik F. Franco, Johan R. Meinardi, Saskia Middeldorp, Elisabeth C. M. Van Pampus
Publikováno v:
British Journal of Haematology. 111:118-121
Autor:
Okke de Weerdt, Marleen Luten, René van der Griend, Anneke Brand, Ronnie van der Holt, Peter A. W. te Boekhorst, Jaap Jan Zwaginga, Sonja Zweegman, Art Vreughdenhil, Elisabeth C. M. Van Pampus, Bart J. Biemond, P. C. Huijgens, Mark Levin, Harry R. Koene, Rene Hollestein, Hans Pruijt
Publikováno v:
Blood, 116(21), 1042-1042
Zwaginga, J J, van der Holt, R, Biemond, B J, Boekhorst, P A W, Levin, M, Vreughdenhil, A, Huijgens, P C, Brand, A, van der Griend, R, Luten, M, Pruijt, H, de Weerdt, O, van Pampus, E, Zweegman, S, Hollestein, R & Koene, H R 2010, ' Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients: ' . < http://www.mendeley.com/research/interim-analysis-dutch-hovon-multicenter-randomized-open-label-phase-ii-trial-3-rituximab-dosing-sch >
Zwaginga, J J, van der Holt, R, Biemond, B J, Boekhorst, P A W, Levin, M, Vreughdenhil, A, Huijgens, P C, Brand, A, van der Griend, R, Luten, M, Pruijt, H, de Weerdt, O, van Pampus, E, Zweegman, S, Hollestein, R & Koene, H R 2010, ' Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients: ' . < http://www.mendeley.com/research/interim-analysis-dutch-hovon-multicenter-randomized-open-label-phase-ii-trial-3-rituximab-dosing-sch >
Abstract 2514 The overall short term effectivity of Rituximab in the treatment of ITP is reported to be around 50%. In most studies the traditional CD20 dosing scheme of 4 weekly interspaced 375 mg/m2 doses is used although other single-arm studies s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91342096607e19be0be834be6df27b24
http://hdl.handle.net/1887/118378
http://hdl.handle.net/1887/118378
Autor:
Johan W. M. Heemskerk, Paola E. J. van der Meijden, Elisabeth C. M. Van Pampus, Rene van Oerle, Joyce Curvers, Saskia E M Schols
Publikováno v:
Thrombosis and Haemostasis, 99, 1, pp. 64-70
Thrombosis and Haemostasis, 99, 64-70
Thrombosis and Haemostasis, 99, 64-70
Contains fulltext : 69751.pdf (Publisher’s version ) (Closed access) In a clinical setting, fresh frozen plasma (FFP) is transfused to diluted patients with complicated surgery or trauma, as guided by prolonged conventional coagulation times or low
Autor:
Evi Theunissen, Sandra Cauwenberghs, Elisabeth C. M. Van Pampus, Marion A.H. Feijge, Joyce Curvers, Johan W. M. Heemskerk
Publikováno v:
British journal of haematology. 136(3)
Currently, patients developing severe thrombocytopenia during chemotherapy treatment are prophylactically transfused with platelets. We developed two platelet function tests to report the improved haemostasis in the transfused patients, which were ca